REDLANDS, Calif., Aug. 11, 2017 /PRNewswire/ -- Renovis Surgical Technologies, Inc. announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market posterior lumbar Tesera® porous titanium interbody fusion systems.
These systems...
For more information, please visit
http://www.prnewswire.com/news-releases/[...]-fusion-systems-300503104.html